Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Institute for Nursing Science, University of Education Schwäbisch Gmünd, Schwäbisch Gmünd, Germany.
Int J Obes (Lond). 2023 Sep;47(9):833-840. doi: 10.1038/s41366-023-01328-y. Epub 2023 Jul 7.
BACKGROUND/OBJECTIVES: Some individuals with overweight/obesity may be relatively metabolically healthy (MHO) and have a lower risk of cardiovascular disease than those with metabolically unhealthy overweight/obesity (MUO). We aimed to compare changes in body weight and cardiometabolic risk factors and type 2 diabetes incidence during a lifestyle intervention between individuals with MHO vs MUO.
This post-hoc analysis included 1012 participants with MHO and 1153 participants with MUO at baseline in the randomized trial PREVIEW. Participants underwent an eight-week low-energy diet phase followed by a 148-week lifestyle-based weight-maintenance intervention. Adjusted linear mixed models and Cox proportional hazards regression models were used.
There were no statistically significant differences in weight loss (%) between participants with MHO vs MUO over 156 weeks. At the end of the study, weight loss was 2.7% (95% CI, 1.7%-3.6%) in participants with MHO and 3.0% (2.1%-4.0%) in those with MUO. After the low-energy diet phase, participants with MHO had smaller decreases in triglyceride (mean difference between MHO vs MUO 0.08 mmol·L [95% CI, 0.04-0.12]; P < 0.001) but similar reductions in fasting glucose and HOMA-IR than those with MUO. However, at the end of weight maintenance, those with MHO had greater reductions in triglyceride (mean difference -0.08 mmol·L [-0.12--0.04]; P < 0.001), fasting glucose, 2-hour glucose (difference -0.28 mmol·L [-0.41--0.16]; P < 0.001), and HOMA-IR than those with MUO. Participants with MHO had smaller decreases in diastolic blood pressure and HbA and greater decreases in HDL cholesterol after weight loss than those with MUO, whereas the statistically significant differences disappeared at the end of weight maintenance. Participants with MHO had lower 3-year type 2 diabetes incidence than those with MUO (adjusted hazard ratio 0.37 [0.20-0.66]; P < 0.001).
Individuals with MUO had greater improvements in some cardiometabolic risk factors during the low-energy diet phase, but had smaller improvements during long-term lifestyle intervention than those with MHO.
背景/目的:一些超重/肥胖个体可能相对代谢健康(MHO),患心血管疾病的风险低于代谢不健康的超重/肥胖个体(MUO)。我们旨在比较 MHO 与 MUO 个体在生活方式干预期间体重和心血管代谢危险因素的变化以及 2 型糖尿病的发病率。
这是一项随机试验 PREVIEW 的事后分析,纳入了基线时 1012 名 MHO 个体和 1153 名 MUO 个体。参与者接受了为期 8 周的低能量饮食阶段,然后进行了为期 148 周的基于生活方式的体重维持干预。使用调整后的线性混合模型和 Cox 比例风险回归模型。
在 156 周内,MHO 与 MUO 个体的体重减轻百分比无统计学差异。研究结束时,MHO 个体的体重减轻 2.7%(95%CI,1.7%-3.6%),MUO 个体的体重减轻 3.0%(2.1%-4.0%)。在低能量饮食阶段后,MHO 个体的甘油三酯降低幅度较小(MHO 与 MUO 之间的平均差异为 0.08mmol·L [95%CI,0.04-0.12];P<0.001),但空腹血糖和 HOMA-IR 的降低幅度与 MUO 个体相似。然而,在体重维持结束时,MHO 个体的甘油三酯降低幅度更大(差异为-0.08mmol·L[-0.12--0.04];P<0.001),空腹血糖、2 小时血糖(差异为-0.28mmol·L[-0.41--0.16];P<0.001)和 HOMA-IR 也低于 MUO 个体。与 MUO 个体相比,MHO 个体在体重减轻后舒张压和 HbA 的降低幅度较小,HDL 胆固醇的降低幅度较大,但在体重维持结束时,这些差异消失。MHO 个体的 3 年 2 型糖尿病发病率低于 MUO 个体(调整后的危险比为 0.37[0.20-0.66];P<0.001)。
MUO 个体在低能量饮食阶段某些心血管代谢危险因素的改善程度更大,但在长期生活方式干预期间的改善程度小于 MHO 个体。